Sign Up to like & get
recommendations!
0
Published in 2017 at "Annals of Hematology"
DOI: 10.1007/s00277-017-3000-3
Abstract: Dear Editor, Lineage switch between myeloid and lymphoblastic leukemia is a rare but interesting event as its exploration might give insights into pathways responsible for lineage assignment and development of leukemia. Lineage switch describes an…
read more here.
Keywords:
second allogeneic;
lineage;
lymphoblastic leukemia;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3454-y
Abstract: Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal prognosis and further therapeutic options are limited. One potential curative…
read more here.
Keywords:
second allogeneic;
relapsed acute;
hct;
survival ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15973
Abstract: Although second allogeneic haematopoietic cell transplantation (allo‐HCT2) is a therapeutic option for patients relapsing after first HCT (allo‐HCT1), there is limited data on allo‐HCT2 in patients with acute lymphoblastic leukaemia (ALL).
read more here.
Keywords:
second allogeneic;
patients acute;
cell transplantation;
transplantation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-140669
Abstract: Background. Relapse after allogeneic haematopoietic stem cell transplantation (HSCT) is associated with very poor outcomes. A myeloablative conditioning regimen for patients with advanced acute leukemia before second allogeneic HSCT is crucial to better control the…
read more here.
Keywords:
patients advanced;
second allogeneic;
acute leukemia;
day ... See more keywords